Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment

Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors

Xiaopin Duan, Christina Chan, Wenbo Han et al. · Nature Communications · 2019 · 253 citations · Full text

Medicine, Oncology, Pharmacology +17

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

Sandra M. Swain, M. E. Lippman, Elizabeth Egan et al. · Journal of Clinical Oncology · 1989 · 242 citations

Medicine, Pharmacology, Pharmacotherapy +17

Bevacizumab in Stage II-III Colon Cancer: 5-Year Update of the National Surgical Adjuvant Breast and Bowel Project C-08 Trial

Carmen J. Allegra, Greg Yothers, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2012 · 208 citations

Medicine, Oncology, Pharmacotherapy +16

Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis

Jianfeng Guo, Zhuo Yu, Manisit Das et al. · ACS Nano · 2020 · 199 citations

Medicine, Oncology, Pharmacology +17

A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer

Dandan Sun, Yifang Zou, Shulan Han et al. · Acta Pharmaceutica Sinica B · 2021 · 185 citations · Full text

Medicine, Oncology, Pharmacology +17